Burdica Biomed Ltd (BBL) is a high growth medical device biotechnology using hyaluronic acid (HA) based technology platforms to develop several new products in key markets including: reproductive health, aesthetics, urology and wound care. BBL has unique expertise in the field of advanced medical bioploymers which have the advantage of being biocompatible and degradable in nature.
Their use in the medical arena is relatively new, but already there is a strong market uptake for research and product demand.
Click here for more information on Burdica.
